Molekule Consulting (“Molekule”) is a recognized global leader in the development and refinement of primary competitive insights and intelligence for the biopharmaceutical and life sciences industries. Molekule aligns intelligence outcomes, focuses results and enables our client partners the ability to “win” in the highly dynamic and competitive biopharmaceutical space. Engaging with biopharmaceutical companies to provide accurate and actionable intelligence, Molekule Consulting remains a trusted partner of biopharmaceutical players today and tomorrow.
Lifescience Dynamics Limited is a specialist in primary human intelligence providing new intelligence – i.e. not known to our clients previously. Clients hire us to collect ‘high value intelligence’ which may impact on their strategic decisions. Our clients expect to receive “hard intelligence” which is not in the public domain, which is not written or published anywhere and certainly not available through any commercial databases.
Since 1992, trusted experts in primary regulatory, commercial and clinical CI research across 14 therapy areas and medical devices in N. America, Europe, APJ and LatAm – strong emerging market presence:
• Unique, best-in-class regulatory intelligence practice
• Systematic CI tracking programs
• Innovative competitor simulation workshops
• Strategic scenario planning workshops
• Strategic market opportunity/threat assessments
• Seasoned conference coverage methodologies
• Sensitive data leakage assessments & counter-intelligence seminars.
Atacana Group, Inc. is a new generation provider of competitive intelligence and strategy products for the pharmaceutical industry.
We deliver superior insights and a unique partnership by providing you with:
• A trusted cross-functional team with experience working in Pharma companies
• An innovative CI approach using Agile methodologies and digital tools
• A high-quality product through proven CI principles and processes
Our strength is managing large programs supporting:
• Potential blockbuster products that are in Phase 3 or that have recently launched
• Blockbuster products that are launching new indications
Our products include Ongoing Monitoring, Conference Insights, Deep Dives and CI Alerts.
CHR works exclusively with companies in the life science sector, from the world’s largest biopharmaceutical companies, through to one-asset start-ups, providing strategic decision support, action planning and competitive intelligence, in addition to tailored landscape analyses, commercial opportunity assessments, market modelling and product sales forecasting. Our evaluation of market-player activity, intent and capabilities, combined with a targeted understanding of key trends in prescriber, regulator, and payer environments, enables our clients to make key decisions from an optimally informed position.
Deallus is a unique strategic intelligence consultancy operating across the global life sciences sector. Our mission is simple: to prepare you for the future by delivering the forward-thinking assurance you need in an uncertain and highly competitive world. The knowledge and clarity we provide helps life sciences companies shape future markets by making the right strategic decisions with confidence.
Dig Worldwide is a specialist agency founded in 2011 providing back-to-basics primary competitive intelligence. We spend time talking to informed people rather than passively searching the internet and recycling information. Everything that Dig Worldwide does is based on asking the right questions of both our clients and potential sources of intelligence.
Evaluate provides trusted commercial intelligence for the pharmaceutical industry. We help our clients to refine and transform their understanding of the past, present, and future of the global pharmaceutical market to drive better decisions. When you partner with Evaluate, our constantly expanding solutions and our transparent methodologies and datasets are instantly at your disposal, along with personalised, expert support.
Evaluate gives you the time and confidence to turn understanding into insight, and insight into action.
Since 1988, Fletcher/CSI, a leading global life-science consulting and research company, provides life sciences companies with in-depth primary research and competitive deep dives, War Game and Scenario Planning strategy session development and facilitation, medical congress and trade show data collection, and Win/Loss sales evaluations. Fletcher/CSI’s customized consulting services allows Senior, Brand, Business Development and Strategic Planning managers to make better decisions that maximize revenues, identify market opportunities that lead to further revenue growth and anticipate competitor actions. Fletcher/CSI’s experienced pharmaceutical brand consulting, research and medical specialists team combines both life science business acumen with therapeutic expertise to deliver in-depth insight and analysis into current and future market and competitor events and trends. Fletcher/CSI, headquartered in Williston, Vermont has global primary and secondary research capabilities. Our global network consists of offices in every major pharmaceutical market and clinical trial initiative around the world.
Pennside Partners is a leading business development consulting firm serving the pharmaceutical, biotechnology, and medical device sectors worldwide.
Pennside remains a top choice by many pharma and biotech companies for our consistency in delivering high-quality, actionable business insight, and competitive intelligence.
PharmaForce International is the leader in benchmarking pharmaceutical sales, marketing and medical affairs operations globally. Leading pharmaceutical and biotech companies throughout the world utilize PharmaForce’s primary source research to uncover the strategies and tactics of their competitors. With a database of over 30,000 contacts at all levels of the industry, PharmaForce’s industry-experienced researchers can quickly obtain information on sales force deployment, compensation levels, organizational structures, marketing spend and overall commercial and medical strategies for your key competitors any where around the world.
Prescient Healthcare Group, founded in 2007, is a pharmaceutical product and portfolio strategy firm. We support our clients’ efforts in developing targeted and differentiated clinical and commercial value propositions throughout a product’s life cycle. We ensure our clients have in-depth insight into what the future market scenario will look like and the value their products will need to demonstrate to both resonate with the market’s evolving needs and differentiate from the competition. We then work with our clients to develop strategies at key points that determine long-term success through two distinct businesses.
In our Insights & Analytics Business, we provide highly-valued and dynamic intelligence support to assets and brands from early clinical development through to loss of exclusivity.
In our Advisory Business, we combine our deep understanding of assets, brands, and disease areas with a robust problem-solving toolkit to identify new sources of value at critical milestones along the product’s life cycle.
Prescient has been a portfolio company of Baird Capital since 2017. We have offices in London, New York, San Francisco, New Delhi and Beijing.
For more information on Prescient Healthcare Group, please visit: www.prescienthg.com
SAI, established over 30 years ago, has a focused vision of providing clients with a new standard of decision support grounded in an intensive field oriented business research methodology, The heart of our value proposition remains our global team of over 300 professionals and their unwavering commitment to excellence and the success of our clients. We are passionate about one thing: helping you win in the market.
Discover. Learn. Achieve.
Springer Nature is a world leading research, educational and professional publisher, providing quality content to our communities through a range of innovative platforms, products and services. Every day, around the globe, our imprints, books, journals and resources reach millions of people – helping researchers, students, teachers & professionals to discover, learn and achieve more.
Through our family of brands we aim to be serve and support the research, education and professional communities by putting them at the heart of all we do, delivering the highest possible standards in content and technology, and helping shape the future of publishing for their benefit and society overall.
Springer Nature employs almost 13,000 people in over 50 countries around the world. For more information, please visit springernature.com and follow @SpringerNature on Twitter.
TheraTraQ was launched in 2019 and operates as an autonomous division within SAI MedPartners, a leading global strategic intelligence provider to the biopharmaceutical and medical device sectors.
SAI MedPartners’ core business and value proposition have focused on a primary-research methodology to support its strategy development and competitive intelligence engagements. World-class secondary research monitoring and knowledge management capabilities were developed initially as an internal support capability and ultimately as a stand-alone service for clients.
TheraTraQ now offers a full suite of offerings leveraging other unique monitoring, knowledge management and analytical capabilities to offer high value, cost effective competitive intelligence solutions.
Voxx Analytics provides timely visual insight into competitor messaging tactics and promotional strategies. Our comprehensive, digitized library of marketing and promotional literature and innovative track-and-analysis solutions delivers highly relevant, actionable information with precision and ease. Watch your competition’s every marketing move, with Voxx Analytics.